ageing

R&D

Longevity: Anti-ageing drugs, watch out, here we come…

Advances in multi-omics, artificial intelligence (AI), deep learning (DL), ageing biomarkers, precision imaging, ageing clocks, robotics, and smart technologies have enabled researchers to

R&D

an old woman and her middle-aged daughter image for a feature on ageing and neurological conditions

Ageing Europe - It’s time we prioritised neurological condit...

Europeans are living longer than ever before – tangible proof of the phenomenal advancements in science and healthcare.1,2 However, it comes with a paradoxical rise in nervous sy

R&D

Investing in healthspan: A prescription for prosperity

The combined efforts of researchers, investors, and pharmaceutical and biotech companies have resulted in substantial progress in the treatment of major diseases such as cancer, diabetes, a

Patients

A glance back to Pharma Integrates, London 2022 – part iii

Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022.

Patients

Nine for 2023, part two: healthcare’s hard problem, the prog...

The first part of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year,

News

AbbVie, Calico raise their age-related disease alliance fund...

AbbVie and Alphabet spin-out Calico Life Sciences have agreed to fund their seven-year-old partnership seeking treatments for diseases of ageing with another $500 million apiece.